Cargando…

A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures

BACKGROUND: The content validity (appropriateness and acceptability) of patient‐reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) but not adolescents. OBJECTIVES: To explore the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Macey, Jake, Kitchen, Helen, Aldhouse, Natalie V.J., Edson‐Heredia, Emily, Burge, Russel, Prakash, Apurva, King, Brett A., Mesinkovska, Natasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305453/
https://www.ncbi.nlm.nih.gov/pubmed/34811721
http://dx.doi.org/10.1111/bjd.20904
_version_ 1784752329019359232
author Macey, Jake
Kitchen, Helen
Aldhouse, Natalie V.J.
Edson‐Heredia, Emily
Burge, Russel
Prakash, Apurva
King, Brett A.
Mesinkovska, Natasha
author_facet Macey, Jake
Kitchen, Helen
Aldhouse, Natalie V.J.
Edson‐Heredia, Emily
Burge, Russel
Prakash, Apurva
King, Brett A.
Mesinkovska, Natasha
author_sort Macey, Jake
collection PubMed
description BACKGROUND: The content validity (appropriateness and acceptability) of patient‐reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) but not adolescents. OBJECTIVES: To explore the content validity of the suite of AA PRO measures and accompanying photoguides in an adolescent sample. METHODS: Semi‐structured, 90‐min, combined concept elicitation and cognitive interviews were conducted face‐to‐face with adolescents who experienced ≥ 50% AA‐related scalp hair loss. Transcripts underwent thematic and framework analysis. RESULTS: Eleven adolescents (aged 12–17 years, 55% female, 45% nonwhite) diagnosed with AA for 5·9 years (mean) participated. Participants had 69·6% scalp hair (mean) and current eyebrow (82%) and/or eyelash loss (82%) and/or nail involvement (36%). Adolescents reported scalp, eyebrow and eyelash hair loss as their top three most bothersome signs/symptoms. Despite mostly accepting their AA, impacts related to visible areas of hair loss were prominent. Participants demonstrated good understanding and appropriate use of the PRO measures, and advocated including hair loss percentages alongside descriptive categories in the Scalp Hair Assessment PRO™. Results confirmed treatment success thresholds established with adults: achievement of ≤ 20% scalp hair loss, no/minimal eyebrow and eyelash loss, no/a little nail damage and eye irritation (PRO measure categories 0 or 1). CONCLUSIONS: The Scalp Hair Assessment PRO™, PRO Measure for Eyebrows™, PRO Measure for Eyelashes™, PRO Measure for Nail Appearance™ and PRO Measure for Eye Irritation™ and accompanying photoguides are fit‐for‐purpose self‐reported measures of AA signs/symptoms that are impactful to adolescents with AA.
format Online
Article
Text
id pubmed-9305453
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93054532022-07-28 A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures Macey, Jake Kitchen, Helen Aldhouse, Natalie V.J. Edson‐Heredia, Emily Burge, Russel Prakash, Apurva King, Brett A. Mesinkovska, Natasha Br J Dermatol Original Articles BACKGROUND: The content validity (appropriateness and acceptability) of patient‐reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) but not adolescents. OBJECTIVES: To explore the content validity of the suite of AA PRO measures and accompanying photoguides in an adolescent sample. METHODS: Semi‐structured, 90‐min, combined concept elicitation and cognitive interviews were conducted face‐to‐face with adolescents who experienced ≥ 50% AA‐related scalp hair loss. Transcripts underwent thematic and framework analysis. RESULTS: Eleven adolescents (aged 12–17 years, 55% female, 45% nonwhite) diagnosed with AA for 5·9 years (mean) participated. Participants had 69·6% scalp hair (mean) and current eyebrow (82%) and/or eyelash loss (82%) and/or nail involvement (36%). Adolescents reported scalp, eyebrow and eyelash hair loss as their top three most bothersome signs/symptoms. Despite mostly accepting their AA, impacts related to visible areas of hair loss were prominent. Participants demonstrated good understanding and appropriate use of the PRO measures, and advocated including hair loss percentages alongside descriptive categories in the Scalp Hair Assessment PRO™. Results confirmed treatment success thresholds established with adults: achievement of ≤ 20% scalp hair loss, no/minimal eyebrow and eyelash loss, no/a little nail damage and eye irritation (PRO measure categories 0 or 1). CONCLUSIONS: The Scalp Hair Assessment PRO™, PRO Measure for Eyebrows™, PRO Measure for Eyelashes™, PRO Measure for Nail Appearance™ and PRO Measure for Eye Irritation™ and accompanying photoguides are fit‐for‐purpose self‐reported measures of AA signs/symptoms that are impactful to adolescents with AA. John Wiley and Sons Inc. 2022-02-25 2022-05 /pmc/articles/PMC9305453/ /pubmed/34811721 http://dx.doi.org/10.1111/bjd.20904 Text en © 2022 Eli Lilly and Company. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Macey, Jake
Kitchen, Helen
Aldhouse, Natalie V.J.
Edson‐Heredia, Emily
Burge, Russel
Prakash, Apurva
King, Brett A.
Mesinkovska, Natasha
A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
title A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
title_full A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
title_fullStr A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
title_full_unstemmed A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
title_short A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
title_sort qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305453/
https://www.ncbi.nlm.nih.gov/pubmed/34811721
http://dx.doi.org/10.1111/bjd.20904
work_keys_str_mv AT maceyjake aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT kitchenhelen aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT aldhousenatalievj aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT edsonherediaemily aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT burgerussel aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT prakashapurva aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT kingbretta aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT mesinkovskanatasha aqualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT maceyjake qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT kitchenhelen qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT aldhousenatalievj qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT edsonherediaemily qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT burgerussel qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT prakashapurva qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT kingbretta qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures
AT mesinkovskanatasha qualitativeinterviewstudytoexploreadolescentsexperienceofalopeciaareataandthecontentvalidityofsignsymptompatientreportedoutcomemeasures